B. Metzler seel. Sohn & Co. AG Acquires New Shares in Ralliant Corporation $RAL

B. Metzler seel. Sohn & Co. AG acquired a new position in shares of Ralliant Corporation (NYSE:RAL - Free Report) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 23,944 shares of the company's stock, valued at approximately $1,763,000.

Several other large investors have also added to or reduced their stakes in the stock. Cetera Investment Advisers bought a new stake in shares of Ralliant during the second quarter valued at about $700,000. Russell Investments Group Ltd. bought a new position in shares of Ralliant in the second quarter valued at approximately $1,465,000. EverSource Wealth Advisors LLC purchased a new position in Ralliant during the second quarter valued at approximately $39,000. First Trust Advisors LP purchased a new position in Ralliant during the second quarter valued at approximately $2,013,000. Finally, Federated Hermes Inc. bought a new stake in Ralliant during the 2nd quarter worth approximately $326,000.

Ralliant Stock Performance

Shares of NYSE RAL opened at $63.72 on Monday. The stock has a market cap of $7.05 billion, a price-to-earnings ratio of -5.87, a P/E/G ratio of 2.36 and a beta of 1.61. The company has a current ratio of 1.52, a quick ratio of 1.00 and a debt-to-equity ratio of 0.75. Ralliant Corporation has a 1-year low of $37.27 and a 1-year high of $75.41. The stock's 50-day moving average is $68.94 and its 200 day moving average is $55.94.

Ralliant (NYSE:RAL - Get Free Report) last issued its earnings results on Thursday, July 30th. The company reported $0.68 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.63 by $0.05. Ralliant had a positive return on equity of 14.97% and a negative net margin of 56.38%.The business had revenue of $567.80 million during the quarter. Ralliant has set its FY 2026 guidance at 2.760-2.900 EPS and its Q3 2026 guidance at 0.720-0.780 EPS. On average, sell-side analysts anticipate that Ralliant Corporation will post 2.87 EPS for the current fiscal year.

Ralliant Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, September 23rd. Shareholders of record on Tuesday, September 8th will be given a dividend of $0.05 per share. This represents a $0.20 annualized dividend and a yield of 0.3%. The ex-dividend date is Tuesday, September 8th. Ralliant's dividend payout ratio is presently -1.84%.

Insider Transactions at Ralliant

In related news, SVP Karen M. Bick sold 6,062 shares of the stock in a transaction dated Monday, August 17th. The stock was sold at an average price of $72.00, for a total transaction of $436,464.00. Following the completion of the sale, the senior vice president directly owned 31,668 shares in the company, valued at $2,280,096. This represents a 16.07% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Tamara S. Newcombe sold 12,936 shares of the stock in a transaction dated Friday, August 14th. The shares were sold at an average price of $71.79, for a total value of $928,675.44. Following the sale, the chief executive officer owned 251,967 shares of the company's stock, valued at $18,088,710.93. This represents a 4.88% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.42% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

Several brokerages have commented on RAL. Vertical Research downgraded shares of Ralliant from a "buy" rating to a "hold" rating and set a $65.00 price target for the company. in a report on Wednesday, May 27th. BMO Capital Markets initiated coverage on shares of Ralliant in a report on Monday, July 20th. They issued a "market perform" rating and a $78.00 price target on the stock. Morgan Stanley lifted their price objective on Ralliant from $68.00 to $85.00 and gave the company an "overweight" rating in a research note on Tuesday, June 23rd. Weiss Ratings restated a "sell (d)" rating on shares of Ralliant in a research report on Friday, July 31st. Finally, Royal Bank Of Canada upped their target price on Ralliant from $71.00 to $73.00 and gave the stock a "sector perform" rating in a research note on Friday, July 31st. One research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, three have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average target price of $75.70.

About Ralliant

Ralliant, Inc NYSE: RAL is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient's own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company's core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source